Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 15 of 15

List	Outcome	Time frame
Primary	Percentage of patients with HBsAg-associated HCC post-therapy	Week 4-240
Primary	Hepatocellular Carcinoma (HCC) Incidence	Week 4-240
Secondary	Number of chronic hepatitis B (CHB) patients with accurate knowledge/awareness of HBV	Week 4-240
Secondary	Rate of HBsAg seroclearance	Week 4-240
Secondary	HBsAg seroconversion rate	Week 4-240
Secondary	Number of patients with altered HBsAg levels post-treatment	Week 4-240
Secondary	Number of patients with HBsAg level decline from baseline	Week 4-240
Secondary	HBeAg seroconversion rate	Week 4-240
Secondary	HBV DNA	Week 4-240
Secondary	Liver fibrosis improvement rate	Week 4-240
Secondary	Incidence of liver cirrhosis	Week 4-240
Secondary	Incidence of decompensated cirrhosis	Week 4-240
Secondary	Incidence of decompensation-related complications	Week 4-240
Secondary	Liver transplantation incidence rate	Week 4-240
Secondary	Post-treatment relapse rate	Week 4-240

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07169656/registered